This website uses cookies, including third party ones, to allow for analysis of how people use our website in order to improve your experience and our services. By continuing to use our website, you agree to the use of such cookies. Click here for more information on our and .
Recently, we have asked our readers to participate in an opinion poll on the most important issues in Healthcare Technology Assessment (HTA). We are now pleased to share the results with you. 57% of all poll participants thought that engaging with consumers and incorporating patient perspectives in the assessment process is at the top of the priority list for HTA. 29 % of respondents gave their vote to disinvesting from devices, diagnostics or drugs that have become ‘low value’. Only 14% of voters gave the exploration of new assessment methods for low risk technologies that enable a quicker entry to market the highest priority. You can see a visual representation of the results below.
Finding the right model of health technology assessment for device technologies and diagnostics is an important issue on this year’s agenda at the 2nd annual Health Technology Assessment Conference. In the lead-up to the event in December, we had the chance to speak to Peggy McBride, PhD, Health Economics and Outcomes Manager, Medtronic, ANZ about current assessment methods and the benefits of improving clinician engagement. You can read the interview here.
